(ALGN) Align Technology - Ratings and Ratios

Align Technology, Inc. is a leader in digital orthodontics and dentistry, best known for its Invisalign clear aligners and iTero intraoral scanners. The company operates in a niche but growing market, capitalizing on the shift from traditional metal braces to more discreet and efficient orthodontic solutions. Its products are used by orthodontists and general practitioner dentists worldwide, with a strong presence in the U.S., Switzerland, and other international markets.

The Clear Aligner segment is the companys core business, offering a range of Invisalign products tailored to different patient needs. For younger patients, aged 6 to 10, the Invisalign First system addresses mixed dentition cases, accommodating tooth eruption and compliance. For older patients, the comprehensive Invisalign package includes mandibular advancement and other features. The segment also offers Invisalign Moderate, Lite, and Express options, catering to cases requiring less complex treatment. Retention products and tools like the Invisalign Palatal Expander, a 3D-printed orthodontic device, further complement the offering.

The Imaging Systems and CAD/CAM Services segment provides the iTero intraoral scanning system, a versatile tool for restorative and orthodontic procedures. This segment also includes software solutions for general practitioners, prosthodontists, and orthodontists, enabling digital records storage, diagnosis, and fabrication of printed models. The Invisalign Outcome Simulator and TimeLapse technology enhance patient consultations and treatment monitoring, while subscription-based services, disposables, and CAD/CAM software solutions round out the offering.

Founded in 1997 and headquartered in Tempe, Arizona, Align Technology has established itself as a pioneer in the medtech space. The company’s focus on innovation, particularly in 3D printing and digital workflows, positions it well in a competitive market. With a market cap of $16.3 billion and a P/E ratio of 38.92, the stock reflects the company’s growth potential and profitability in the health care supplies industry.